Abstract:Abstract Objective: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. T cells are very important in the body's anti-tumor process. However, in HCC, T cell exhaustion not only makes it difficult to implement CAR-T therapy, but also reduces the body's anti-tumor ability or even promotes tumor development. Therefore, it is urgent to explore the relationship between positive regulators of T cells proliferation and HCC. Methods: HCC transcriptome and clinical data were collected from TCGA and ICGC databases. Differentially expressed T-cell positive regulators in the TCGA dataset were analyzed using the R software "limma" package. Univariate COX and Least Absolute Value Convergence and Selection Operator (LASSO) regression analysis established a T cell positive regulator prognostic model, and further combined the risk score with clinicopathological features to construct a nomogram. Single-gene enrichment analysis (ssGSEA) was performed using the R software "gva" package to compare the proportion of immune cells between high and low score groups, and gene set variation (GSVA) to identify significantly enriched signaling pathways in high and low score groups. The "pRRophetic" R software package analyzes the susceptibility of patients with high and low scores to chemotherapy. Further, GO and KEGG pathway enrichment analysis was performed on the differential genes in the high and low score groups, and the "cytoHubba" software was used to find the key differential genes in the high and low score groups.Results: A total of 33 positive regulators of T cell proliferation were identified, and 617 HCC patients were included in the analysis. Among them, 23 T cell positive regulators were significantly differentially expressed in HCC (P<0.05). Patients with high scores in the TCGA dataset had poorer prognosis than those with lower scores, and the results were consistent with the validation results in the ICGC dataset (P<0.05). The levels of antigen-presenting cells, major histocompatibility complex-I, chemokine receptors and immune checkpoints in the high-scoring group were significantly increased (P<0.05). The IC50 values of 5-FU, doxorubicin and mitomycin were significantly lower in the high score group (P<0.05). The highly expressed genes in the high score group were mainly enriched in signaling pathways such as RNA degradation, cell cycle, mismatch repair, and DNA replication, and the highly expressed genes in the low score group were mainly enriched in metabolism-related pathways. The top three key differential genes in the high and low risk groups were CDK1, KIF11, and TOP2A. The prognosis of HCC patients with high expression of CDK1 and low expression was significantly worse (P<0.05), and it was related to clinical stage.Conclusion: The positive regulators of T cell proliferation are significantly differentially expressed in HCC, and the overexpression of related genes brings hope for the application of CAR-T therapy in HCC. The prognostic model of T cell positive regulators promotes the understanding of the characteristics of HCC tumor immune microenvironment infiltration and drug sensitivity, and provides a theoretical basis for the clinical treatment of HCC.

Role of Transcription Factor T-bet, GATA-3, RORγt and FOXP3 in Peripheral Blood Mononuclear Cell of Patients with Hepatocellular Carcinoma

The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance.

Expression of T-bet and GATA-3 in Peripheral Blood Mononuclear Cells of Patients with Psoriasis Vulgaris

Characterization of Genomic Alterations, Tumor Mutational Burden and PDL1 Expression in 181 Chinese Hepatocellular Carcinomas.

Expression of Transforming Growth Factor Β 1 in Patients with Hepatocellular Carcinoma and Its Clinical Value

Rog, Gata3, and T-Bet Mrna Levels in Peripheral Blood Mononuclear Cells in Patients with Chronic Hepatitis B

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients

Peripheral blood Th17 and CD4 + CD25+ regulatory T cell levels and their correlations in patients with primary hepatocellular carcinoma

Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues

Genes Expression Profiling of Peripheral Blood Cells of Patients with Hepatocellular Carcinoma

Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma.

Prognostic Significance of Regulatory T Lymphocytes in Patients with Hepatocellular Carcinoma

[The Frequency, Phenotypes and Functions of CD4+ CD25+ Regulatory T Cells in Hepatocellular Carcinoma Patients].

Characterization of positively regulate T cell proliferation-related genes in hepatocellular cancer to guide clinical therapy

Intratumoral Regulatory T Cells with Higher Prevalence and More Suppressive Activity in Hepatocellular Carcinoma Patients

Identification of a FOXP3(+)CD3(+)CD56(+) Population with Immunosuppressive Function in Cancer Tissues of Human Hepatocellular Carcinoma.

Study on the tumor infiltrating T lymphocytes subsets in HCC patients

FOXP3 is a HCC Suppressor Gene and Acts Through Regulating the TGF-β/Smad2/3 Signaling Pathway

Treg/Th17 imbalance and its clinical significance in patients with hepatitis B-associated liver cirrhosis

[Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].